文献速递肝胆胰外科

机器人辅助与腹腔镜扩大左胰腺切除术:泛欧洲多中心倾向性评分匹配分析

Robot-assisted and Laparoscopic Extended Left Pancreatectomy: A Pan-European Multicenter Propensity-score Matched Analysis.
PubMed 文献 · Ann Surg · 2025-06-23

该泛欧洲多中心研究纳入2012-2022年19国72中心的514例扩大左胰腺切除患者(152例机器人辅助,362例腹腔镜),经1:1倾向性评分匹配后各119例。匹配后两组主要并发症、出血量、中转率、死亡率及住院时间均无显著差异,但机器人辅助组手术时间更长(中位277 vs 228分钟,P<0.001)。

要点

  • 匹配后机器人辅助与腹腔镜扩大左胰腺切除的主要并发症率无显著差异(23.5% vs 26.5%,P=0.599)。
  • 机器人辅助组手术时间显著更长(中位277 vs 228分钟,P<0.001)。
  • 机器人辅助更多用于血管侵犯及多器官联合切除等更复杂病例。

核心结论

  • 匹配后扩大机器人辅助左胰腺切除与扩大腹腔镜左胰腺切除的术后结局无显著差异,但机器人辅助手术时间更长。

研究设计与样本

  • 国际多中心回顾性队列研究,纳入2012-2022年19个欧洲国家72个中心的514例扩大左胰腺切除患者(152例机器人辅助,362例腹腔镜)。
  • 扩大切除依据ISGPS定义,采用1:1倾向性评分匹配(卡钳值0.1),主要终点为Clavien-Dindo≥III级并发症。

主要发现

  • 匹配前机器人辅助组更多胰尾肿瘤(69.4% vs 50.0%,P=0.001)、血管侵犯(30.3% vs 16.3%,P<0.001)及>2个额外器官切除(28.5% vs 10.7%,P<0.001)。
  • 匹配前两组主要并发症率相当(27.0% vs 27.0%,P=0.991),机器人辅助组中转率更低(15.1% vs 23.5%,P=0.033)。
  • 匹配后两组主要并发症(23.5% vs 26.5%,P=0.599)、出血量(200 vs 150 mL,P=0.835)、中转率(16.0% vs 20.0%,P=0.422)、30天/住院死亡率(1.7% vs 3.4%,P=0.408)及住院时间(中位7 vs 7天,P=0.906)均无显著差异。
  • 匹配后机器人辅助组手术时间更长(中位277 vs 228分钟,P<0.001)。

临床怎么用

  • 在扩大左胰腺切除中,机器人辅助可考虑用于更复杂病例(如血管侵犯、多器官联合切除),其严重并发症率与腹腔镜相当。
  • 选择机器人辅助时需权衡更长的手术时间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare postoperative outcomes after extended robot-assisted left pancreatectomy (e-RLP) and extended laparoscopic left pancreatectomy (e-LLP). SUMMARY BACKGROUND DATA: The implementation of RLP is increasing worldwide with expanding indications, resulting in more extended resections. However, the use of e-RLP has not been investigated before. METHODS: International study including consecutive patients after e-RLP and e-LLP for all indications in 19 European countries (2012-2022). Extended resection was defined according to the ISGPS definition. Propensity score matching (PSM) was performed in a 1:1 ratio with a caliper width of 0.1. Primary endpoint was major morbidity (Clavien-Dindo grade ≥III complications). RESULTS: Overall, 514 patients were included from 72 centers (152 e-RLPs; 362 e-LLPs). Before PSM, e-RLP patients had more tail tumors (69.4% vs 50.0%, P=0.001), vascular involvement (30.3% vs 16.3%, P<0.001) and >2 additional organ resections (28.5% vs 10.7%, P<0.001), with comparable major morbidity rates (27.0% vs 27.0%, P=0.991) and a lower conversion rate (15.1% vs 23.5%, P=0.033), compared to e-LLP. After PSM, 119 e-RLP patients were matched to 119 e-LLP patients. No significant differences were observed in major morbidity (23.5% vs 26.5%, P=0.599), blood loss (200 vs 150 mL, P=0.835), conversion rate (16.0% vs 20.0%, P=0.422), 30-day/in-hospital mortality (1.7% vs 3.4%, P=0.408), and hospital stay (median 7 vs 7 days, P=0.906). E-RLP had longer operative times (median 277 vs 228 min, P<0.001). CONCLUSIONS: This pan-European cohort study found no significant differences in the outcomes among matched patients undergoing e-RLP and e-LLP, although e-RLP was associated with a longer operative time. The robot-assisted approach is used for more extensive resections with a comparable major morbidity rate compared to laparoscopy.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Bruna CL, van Ramshorst T, van Hilst J, et al. Robot-assisted and Laparoscopic Extended Left Pancreatectomy: A Pan-European Multicenter Propensity-score Matched Analysis. Ann Surg. 2025. PMID: 40548584. doi:10.1097/SLA.0000000000006812

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。